바이오의약품용 인재·리더 육성 워크샵

2024년 8월 20일(EDT)

바이오의약품 업계에서 인재는 틀림없이 기업의 최대 자산이자 최고의 차별화 요소입니다. 우수한 인재 확보를 최우선으로 하는 것이 귀사의 상업적 목표 달성에 필수적입니다.

이 특별한 모임에는 바이오의약품 기업으로부터 125명 이상의 이해관계자(채용·인사 담당자, 기업 임원, 각 부서 관리자, 투자자, 관련 기업 등)이 참가하여 학습 및 네트워킹, 우수 인재의 채용·유지에 관한 문제에 대처합니다. 이 하루 이벤트는 업계 주도 패널 디스커션, 네트워크 구축에 주력한 프레젠테이션을 마련하고 있습니다. 이 이벤트를 통해 우수한 기업 리더가 유의미한 네트워킹 및 실현 가능한 아이디어 획득하고, 실제 체험의 활용을 통해 기존 인재 전략의 개선 및 신규 전략의 도입을 진행시키고, 사업 목적을 달성할 수 있습니다.

Premier Sponsor:

Strategic Sponsor:

Supporting Sponsor:

Day 1

8월 20일 화요일

Registration and Morning Coffee9:00 am

9:30 am

Co-Chairperson's Opening Remarks

Niamh Alix, Chief Human Resources Officer, Prime Medicine Inc.

9:30 am

Co-Chairperson's Opening Remarks

Mara Strandlund, Chief People Officer, National Resilience Inc.

9:35 am

MARKET STRATEGY PRESENTATION: Talent R&D-Understanding the Biopharma Industry's Workforce Challenges

Timothy Oyer, Vice President, RPO Solutions, Advanced RPO

While massive shifts are underway across the world of work, the biopharmaceutical industry is fighting through its fair share of talent scarcity, recruitment, and retention challenges. These are problems that must be solved in order to develop a strategic business agenda that prioritizes scalability, speed, and innovation in an accelerated digital environment. Today’s talent decisions will have a lasting impact on whether your organization thrives or simply survives tomorrow.

9:45 am

PANEL DISCUSSION: The Power of Your Brand and Culture

PANEL MODERATOR:

Benjamin P Locwin, PhD, Executive, Subject Matter Expert, Life Sciences, Black Diamond Networks

In today's dynamic recruitment landscape, staying ahead requires adapting to change and embracing innovation. Achieving acquisition objectives demands actionable strategies and diligent execution. Prioritizing meaningful DEI initiatives fosters inclusivity and equity. Cultivating an impactful culture strategy fuels growth and fosters a supportive environment. Success lies in constant evaluation, adaptation, and commitment to organizational values and goals.

PANELISTS:

Melanie Manning, Chief People Officer, Seismic Therapeutic

Abbey Wolff, Director & Human Resources Business Partner, R&D & ExM, Servier Pharmaceuticals

Philip Vanek, CTO, Gamma Biosciences

10:25 am PANEL DISCUSSION:

Building Agility into Your Acquisition Strategies

PANEL MODERATOR:

Ryan Feeney, Director of Business Development, Advanced RPO

Navigating a rapidly right-sizing industry demands adept recruitment adjustments and strategic maneuvers. Companies must comprehend industry dynamics, adapting recruitment approaches locally and internationally. Emphasizing geographic advantages aids in talent attraction. Meanwhile, in the competitive acquisition arena, winning strategies encompass robust employer branding, enticing incentives, and the fostering of growth opportunities. Success hinges on agile adaptation and savvy talent acquisition amidst industry flux.

PANELISTS:

Stacey Veysey, Talent Acquisition Leader, Vertex Pharmaceuticals Inc.

Mara Strandlund, Chief People Officer, National Resilience Inc.

Jessica D Davis, Principal, Investments, Avant Bio

Jo-Ellen Petrone, Global Talent Acquisition Leader, Lantheus

11:05 amNetworking Coffee Break

11:30 am PANEL DISCUSSION:

Prioritizing Talent Retention and Build Strategies

PANEL MODERATOR:

Niamh Alix, Chief Human Resources Officer, Prime Medicine Inc.

Navigating organizational growth demands adaptability and expert guidance. Transitioning from clinical to commercial necessitates strategic shifts towards marketing and distribution. Managing a hybrid workforce requires technology-enabled collaboration and clear communication. Retaining talent long-term involves fostering a positive work culture, offering growth opportunities, and promoting work-life balance alongside compensation. Balancing these elements ensures sustainable growth and a thriving organizational ecosystem.

PANELISTS:

Ran Zheng, CEO, Landmark Bio

Angela Consani, CEO & Founder, Bioscience Core Skills Institute

Adam J. Thomas, Chief People and Experience Officer, MOMA Therapeutics

Courtney Paynter, Senior Director, Talent Management and Organizational Excellence, AbbVie

Networking Lunch12:10 pm

1:00 pm

Chairperson's Remarks

Mara Strandlund, Chief People Officer, National Resilience Inc.

1:05 pmFIRESIDE CHAT: Connecting Academia, Science, Business and Community

This candid dialogue between two nationally recognized leaders in biotechnology education providea insight into how Massachusetts and North Carolina are creating and enhancing life science talent. Highlighting initiatives like BioConnects NE, Pathmaker (MA) and BioWork (NC) programs, this discussion describes successful methods of engaging industry, academia, government, and the non-profit sector to realize the full potential of regional life science ecosystems. Challenges and areas for improvement will be highlighted.

Interviewee

Jared Auclair, PhD, Director, Bioinnovation; Associate Teaching Professor, Chemistry & Chemical Biology, Northeastern University

Interviewee

Russ Read, Executive Director, National Center Biotechnology Workforce, Forsyth Tech

Interviewed By:

Karla Talanian, Founder, Longview Workforce Advising

1:30 pm PANEL DISCUSSION:

Building & Retaining Your Skilled Technical Workforce

PANEL MODERATOR:

Karla Talanian, Founder, Longview Workforce Advising

Skilled technicians are key to building and sustaining any biopharma manufacturing organization. What are the best practices for recruiting new workers? How can companies improve retention rates in their technical workforce? What are the best options for upskilling technicians with high potential? This panel provides a comprehensive overview of training providers and how your company can find the right partner to efficiently grow and develop your technical workforce.

PANELISTS:

Sunny Schwartz, CEO, Massachusetts Biotechnology Educational Foundation

Mariluci Bladon, Chair of Biotechnology, Middlesex Community College

John Doyle, Education Director, Gloucester Biotechnology Academy

Michelle Lewis, PhD, Executive Director Biopharmaceuticals Education & Training, Stack Family Center for Biopharmaceutical Education and Training (CBET)

Michael Stanger, Senior Clinical Lab Manager, Northeastern University

2:10 pm

PANEL DISCUSSION: Approaches to Identify and Develop Existing Talent

PANEL MODERATOR:

Tony Martignetti, Founder/Chief Inspiration Officer, Inspired Purpose Partners

In navigating effective leadership and employee management, it's crucial to identify leadership gaps, leverage employee strengths, and foster cohesion across multiple sites. Achieving unity of purpose ensures everyone's onboard, impacting retention positively. Real-life case studies demonstrate the effectiveness of role pivots in retaining talent. By focusing on these aspects, organizations can cultivate engaged teams, driving productivity and success while maintaining a satisfied and committed workforce.

PANELISTS:

Lindsay Cox, SHRM-CP, Talent Partner, Biohaven Pharma

Larry Marcin, Vice President, Chemistry & Site Lead, Biohaven Pharmaceuticals, Inc.

Katherine Sellers, Director, Biology & Metabolism, Biohaven Pharmaceuticals, Inc.

Approaches to Identify and Develop Existing Discovery Talent

David A. Pirman, PhD, Vice President, Biology & Biochemistry, Biohaven Pharmaceuticals, Inc.

Biohaven's approach to identifying and recognizing talent within the organization are a direct reflection of our company’s efforts to remain relatively flat with minimal processes and governance. This has allowed for talent to be identified independent of current title or role and these colleagues are recognized accordingly. While fostering an open environment, we strive to ensure all voices can be heard to impact the organization.

Networking Coffee Break2:50 pm

3:10 pm PANEL DISCUSSION:

Balancing and Implementing Right and Downsizing Strategies

PANEL MODERATOR:

Michael L Gamble, President, Taylor Strategy Partners

Navigating change in biotechs involves predicting trends, defining right-sizing versus downsizing, and pre-planning for outcomes. Companies must balance retention and termination packages during workforce adjustments, while leaders should plan for team changes, including their own roles. After changes, maintaining company culture is crucial. By addressing these aspects strategically, biotechs can adapt to challenges and emerge stronger while supporting their employees through transitions.

PANELISTS:

Patrick Lucy, President and CEO, RoslinCT